An Overview of the Genomics of Metabolic Syndrome

Jacquelyn Y. Taylor, Aldi T. Kraja, Lisa de las Fuentes, Ansley Stanfill, Ashley Clark, Ann Cashion

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Purpose: This article provides a brief overview of the diagnostic criteria and genomic risk factors for the components of metabolic syndrome (MetS). Organizing Constructs: Contributions of cardiovascular, obesity, and diabetes genomic risk factors to the development of MetS as reported in the literature have been reviewed. Findings: The genomic risk factors for the development of MetS are strongly linked to the genomic risk factors that make up the components of the disease. Many of the cardiovascular and renal genomic risk factors for MetS development are similar to those found in the development of hypertension and dyslipidemia. Obesity may act as a master trigger to turn on the gene expression changes necessary for the other components of the disease. Studies in the genomics of type 2 diabetes show a number of overlapping genes and polymorphisms that influence both the development of diabetes and MetS. Conclusions: Although health practitioners now have some insights into the genomics of risk factors associated with MetS, the overall understanding of MetS remains inadequate. Clinical applications based on some of the discussed genomic risk factors are being developed but are not yet available for the diagnosis and treatment of MetS. Clinical Relevance: A broad knowledge of the genomic contributions to disease processes will enable the clinician to better utilize genomics to assess and tailor management of patients.

Original languageEnglish (US)
Pages (from-to)52-59
Number of pages8
JournalJournal of Nursing Scholarship
Volume45
Issue number1
DOIs
StatePublished - Mar 1 2013

Fingerprint

Genomics
Obesity
Overlapping Genes
Dyslipidemias
Type 2 Diabetes Mellitus
Hypertension
Kidney
Gene Expression
Health

All Science Journal Classification (ASJC) codes

  • Nursing(all)

Cite this

Taylor, J. Y., Kraja, A. T., de las Fuentes, L., Stanfill, A., Clark, A., & Cashion, A. (2013). An Overview of the Genomics of Metabolic Syndrome. Journal of Nursing Scholarship, 45(1), 52-59. https://doi.org/10.1111/j.1547-5069.2012.01484.x

An Overview of the Genomics of Metabolic Syndrome. / Taylor, Jacquelyn Y.; Kraja, Aldi T.; de las Fuentes, Lisa; Stanfill, Ansley; Clark, Ashley; Cashion, Ann.

In: Journal of Nursing Scholarship, Vol. 45, No. 1, 01.03.2013, p. 52-59.

Research output: Contribution to journalArticle

Taylor, JY, Kraja, AT, de las Fuentes, L, Stanfill, A, Clark, A & Cashion, A 2013, 'An Overview of the Genomics of Metabolic Syndrome', Journal of Nursing Scholarship, vol. 45, no. 1, pp. 52-59. https://doi.org/10.1111/j.1547-5069.2012.01484.x
Taylor, Jacquelyn Y. ; Kraja, Aldi T. ; de las Fuentes, Lisa ; Stanfill, Ansley ; Clark, Ashley ; Cashion, Ann. / An Overview of the Genomics of Metabolic Syndrome. In: Journal of Nursing Scholarship. 2013 ; Vol. 45, No. 1. pp. 52-59.
@article{edb42b6e24f4483ca04be7b760380a71,
title = "An Overview of the Genomics of Metabolic Syndrome",
abstract = "Purpose: This article provides a brief overview of the diagnostic criteria and genomic risk factors for the components of metabolic syndrome (MetS). Organizing Constructs: Contributions of cardiovascular, obesity, and diabetes genomic risk factors to the development of MetS as reported in the literature have been reviewed. Findings: The genomic risk factors for the development of MetS are strongly linked to the genomic risk factors that make up the components of the disease. Many of the cardiovascular and renal genomic risk factors for MetS development are similar to those found in the development of hypertension and dyslipidemia. Obesity may act as a master trigger to turn on the gene expression changes necessary for the other components of the disease. Studies in the genomics of type 2 diabetes show a number of overlapping genes and polymorphisms that influence both the development of diabetes and MetS. Conclusions: Although health practitioners now have some insights into the genomics of risk factors associated with MetS, the overall understanding of MetS remains inadequate. Clinical applications based on some of the discussed genomic risk factors are being developed but are not yet available for the diagnosis and treatment of MetS. Clinical Relevance: A broad knowledge of the genomic contributions to disease processes will enable the clinician to better utilize genomics to assess and tailor management of patients.",
author = "Taylor, {Jacquelyn Y.} and Kraja, {Aldi T.} and {de las Fuentes}, Lisa and Ansley Stanfill and Ashley Clark and Ann Cashion",
year = "2013",
month = "3",
day = "1",
doi = "10.1111/j.1547-5069.2012.01484.x",
language = "English (US)",
volume = "45",
pages = "52--59",
journal = "Journal of Nursing Scholarship",
issn = "1527-6546",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - An Overview of the Genomics of Metabolic Syndrome

AU - Taylor, Jacquelyn Y.

AU - Kraja, Aldi T.

AU - de las Fuentes, Lisa

AU - Stanfill, Ansley

AU - Clark, Ashley

AU - Cashion, Ann

PY - 2013/3/1

Y1 - 2013/3/1

N2 - Purpose: This article provides a brief overview of the diagnostic criteria and genomic risk factors for the components of metabolic syndrome (MetS). Organizing Constructs: Contributions of cardiovascular, obesity, and diabetes genomic risk factors to the development of MetS as reported in the literature have been reviewed. Findings: The genomic risk factors for the development of MetS are strongly linked to the genomic risk factors that make up the components of the disease. Many of the cardiovascular and renal genomic risk factors for MetS development are similar to those found in the development of hypertension and dyslipidemia. Obesity may act as a master trigger to turn on the gene expression changes necessary for the other components of the disease. Studies in the genomics of type 2 diabetes show a number of overlapping genes and polymorphisms that influence both the development of diabetes and MetS. Conclusions: Although health practitioners now have some insights into the genomics of risk factors associated with MetS, the overall understanding of MetS remains inadequate. Clinical applications based on some of the discussed genomic risk factors are being developed but are not yet available for the diagnosis and treatment of MetS. Clinical Relevance: A broad knowledge of the genomic contributions to disease processes will enable the clinician to better utilize genomics to assess and tailor management of patients.

AB - Purpose: This article provides a brief overview of the diagnostic criteria and genomic risk factors for the components of metabolic syndrome (MetS). Organizing Constructs: Contributions of cardiovascular, obesity, and diabetes genomic risk factors to the development of MetS as reported in the literature have been reviewed. Findings: The genomic risk factors for the development of MetS are strongly linked to the genomic risk factors that make up the components of the disease. Many of the cardiovascular and renal genomic risk factors for MetS development are similar to those found in the development of hypertension and dyslipidemia. Obesity may act as a master trigger to turn on the gene expression changes necessary for the other components of the disease. Studies in the genomics of type 2 diabetes show a number of overlapping genes and polymorphisms that influence both the development of diabetes and MetS. Conclusions: Although health practitioners now have some insights into the genomics of risk factors associated with MetS, the overall understanding of MetS remains inadequate. Clinical applications based on some of the discussed genomic risk factors are being developed but are not yet available for the diagnosis and treatment of MetS. Clinical Relevance: A broad knowledge of the genomic contributions to disease processes will enable the clinician to better utilize genomics to assess and tailor management of patients.

UR - http://www.scopus.com/inward/record.url?scp=84874516048&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84874516048&partnerID=8YFLogxK

U2 - 10.1111/j.1547-5069.2012.01484.x

DO - 10.1111/j.1547-5069.2012.01484.x

M3 - Article

VL - 45

SP - 52

EP - 59

JO - Journal of Nursing Scholarship

JF - Journal of Nursing Scholarship

SN - 1527-6546

IS - 1

ER -